What is the relationship between frequent urination and chest pain due to coronary artery disease? How can increased urinary IgM excretion be a factor in this condition? Explore the details in this comprehensive article.

Understanding the Link Between Frequent Urination and Chest Pain

Frequent urination and chest pain can be symptoms that are closely linked, particularly in patients with coronary artery disease. This article delves into the research that has explored the potential relationship between these two seemingly unrelated conditions.

Overactive Bladder and Heart Failure

One key factor that connects frequent urination and chest pain is the relationship between overactive bladder and heart failure. Studies have shown that overactive bladder, a condition characterized by a sudden, intense urge to urinate, is a common distress symptom in patients with heart failure. This suggests that the two conditions may be more closely linked than previously thought.

Prevalence and Socioeconomic Impact of Heart Failure

Heart failure is a growing public health concern, especially in aging societies. In South Korea, for example, the prevalence and socioeconomic burden of heart failure has been on the rise, underscoring the importance of understanding the factors that contribute to this condition.

Factors Related to Heart Failure Readmissions

Research has identified various patient-identified factors that contribute to heart failure readmissions, including both physical and psychological factors. Understanding these factors can help healthcare providers develop more effective strategies for managing and preventing heart failure readmissions.

The Impact of Urinary Incontinence and Overactive Bladder

Urinary incontinence and overactive bladder have been shown to have a significant impact on an individual’s quality of life. This underscores the importance of addressing these conditions, particularly in the context of heart failure and other cardiovascular disorders.

Increased Urinary IgM Excretion in Coronary Artery Disease

The study at the heart of this article focuses on the finding that patients with chest pain due to coronary artery disease have increased urinary IgM excretion. This suggests that the immune system may play a role in the development or progression of coronary artery disease, and that monitoring urinary IgM levels could potentially be a useful diagnostic tool.

Implications and Future Directions

The findings presented in this article have important implications for our understanding of the relationship between frequent urination, chest pain, and underlying cardiovascular conditions. Further research is needed to fully elucidate the mechanisms involved and explore the potential for using urinary biomarkers as a diagnostic tool in the management of cardiovascular disease.

What is the relationship between frequent urination and chest pain due to coronary artery disease?

The relationship between frequent urination and chest pain in patients with coronary artery disease is not entirely clear, but research suggests that it may be mediated through the connection between overactive bladder and heart failure. Overactive bladder, characterized by a sudden, intense urge to urinate, has been identified as a common distress symptom in patients with heart failure. This suggests that the two conditions may be more closely linked than previously thought.

How can increased urinary IgM excretion be a factor in coronary artery disease?

The study at the center of this article found that patients with chest pain due to coronary artery disease had increased levels of urinary IgM, an antibody produced by the immune system. This suggests that the immune system may play a role in the development or progression of coronary artery disease. By monitoring urinary IgM levels, it may be possible to use this as a diagnostic tool to help identify and manage cardiovascular conditions.

What is the prevalence and socioeconomic impact of heart failure in aging societies?

Heart failure is a growing public health concern, particularly in aging societies. In South Korea, for example, the prevalence and socioeconomic burden of heart failure has been on the rise. This underscores the importance of understanding the factors that contribute to the development and progression of heart failure, as well as the need for effective strategies to manage and prevent this condition.

What are some of the patient-identified factors related to heart failure readmissions?

Research has identified various patient-identified factors that contribute to heart failure readmissions, including both physical and psychological factors. These factors can include things like medication adherence, access to healthcare, and the presence of comorbidities. Understanding these factors is crucial for developing more effective strategies to manage and prevent heart failure readmissions.

How do urinary incontinence and overactive bladder impact an individual’s quality of life?

Urinary incontinence and overactive bladder have been shown to have a significant impact on an individual’s quality of life. These conditions can lead to social isolation, emotional distress, and a decreased sense of well-being. Addressing these conditions, particularly in the context of heart failure and other cardiovascular disorders, is important for improving overall health and quality of life.

What are the implications of the findings on increased urinary IgM excretion in coronary artery disease?

The finding that patients with chest pain due to coronary artery disease have increased levels of urinary IgM suggests that the immune system may play a role in the development or progression of this condition. This has important implications for our understanding of the underlying mechanisms of coronary artery disease and the potential for using urinary biomarkers as diagnostic tools. Further research is needed to fully explore these implications and their clinical applications.

Symptom Checker with Body from WebMD

NEW: This symptom checker now includes the ability to select symptoms by body location. We hope this makes it easier for you to identify your symptoms and possible conditions.

The tool also allows you to select multiple symptoms quickly. Click to see FAQs and tips for searching

1) How many body sections are there?

• There are 11 primary body regions and 41 sub-regions from which you can choose. For example, the arm is a primary region, and your elbow is a more specific sub-region. The ability to choose sub-regions allows you to more precisely specify your symptoms.

2) What should I do if I’m not sure which body area to choose?

• Since all symptoms in a sub-region (example “elbow”) are also listed in the primary body region (example “arm”), it is best to start with the primary body region if you are unsure exactly where the symptom is on your body.

3) What if my symptom isn’t associated with a specific body location (for example, “chills”)?

• If you are not sure what body area your symptom falls under, you can type your symptom in the main search box or select the “General Symptoms” category.

• There is also a separate section for skin symptoms only.

4) What if I don’t see my symptom on the list?

• When a body location is selected, the “most common symptoms” are displayed first, but you can also switch tabs to see “All” symptoms.

• You can also use the category-specific search box to search for all symptoms in that category.

• The search box on the main page includes ALL symptoms in all categories.

5) What if I can’t find my condition or my medication on the “Questions” page?

•If your condition or medication is not displayed in the type-ahead list, we don’t have enough information about it to factor it into the results. If you don’t see it, skip that field.

• All questions are optional, you can always skip directly to results.

6) Are there any other tips for using this symptom checker?

• If you need to go back to a previous page, please use the “back” or “previous” buttons within the tool. Do not use the back button on your browser or phone. You could lose the symptoms you entered.

• Results are ordered by how closely your symptoms match a condition AND how common it is (in the United States). Extremely rare conditions may not surface in this tool. You should always consult a doctor for specific concerns.

• We strongly suggest entering more than 1 symptom. It will likely improve your results.

This tool does not provide medical advice It is intended for informational purposes only. It is not a substitute for professional medical advice, diagnosis or treatment. Never ignore professional medical advice in seeking treatment because of something you have read on the WebMD Site. If you think you may have a medical emergency, immediately call your doctor or dial 911.

Overactive Bladder is a Distress Symptom in Heart Failure

1. Tan LB, Williams SG, Tan DK, Cohen-Solal A. So many definitions of heart failure: are they all universally valid? A critical appraisal. Expert Rev Cardiovasc Ther. 2010;8:217–28. [PubMed] [Google Scholar]

2. Palmer MH, Busby-Whitehead J. Relationship between heart failure and overactive bladder. Curr Bladder Dysfunct Rep. 2010;5:18–22. [Google Scholar]

3. Lee H, Oh SH, Cho H, Cho HJ, Kang HY. Prevalence and socioeconomic burden of heart failure in an aging society of South Korea. BMC Cardiovasc Disord. 2016;16:215. [PMC free article] [PubMed] [Google Scholar]

4. Korean National Statistical Office . Daejeon (Korea): Statistics Korea; The annual statistical report of the cause of death 2014. [cited 2016 Mar 1]. Available from: http://www.index.go.kr/potal/main/EachDtlPageDetail.do?idx_cd=1012. [Google Scholar]

5. Retrum JH, Boggs J, Hersh A, Wright L, Main DS, Magid DJ, et al. Patient-identified factors related to heart failure readmissions. Circ Cardiovasc Qual Outcomes. 2013;6:171–7. [PMC free article] [PubMed] [Google Scholar]

6. Bartoli S, Aguzzi G, Tarricone R. Impact on quality of life of urinary incontinence and overactive bladder: a systematic literature review. Urology. 2010;75:491–500. [PubMed] [Google Scholar]

7. Sexton CC, Coyne KS, Thompson C, Bavendam T, Chen CI, Markland A. Prevalence and effect on health-related quality of life of overactive bladder in older americans: results from the epidemiology of lower urinary tract symptoms study. J Am Geriatr Soc. 2011;59:1465–70. [PubMed] [Google Scholar]

8. Andersson KE, Sarawate C, Kahler KH, Stanley EL, Kulkarni AS. Cardiovascular morbidity, heart rates and use of antimuscarinics in patients with overactive bladder. BJU Int. 2010;106:268–74. [PubMed] [Google Scholar]

9. Bouwman II, Voskamp MJ, Kollen BJ, Nijman RJ, van der Heide WK, Blanker MH. Do lower urinary tract symptoms predict cardiovascular diseases in older men? A systematic review and metaanalysis. World J Urol. 2015;33:1911–20. [PMC free article] [PubMed] [Google Scholar]

10. Palmer MH, Hardin SR, Behrend C, Collins SK, Madigan CK, Carlson JR. Urinary incontinence and overactive bladder in patients with heart failure. J Urol. 2009;182:196–202. [PubMed] [Google Scholar]

11. Akkoyun M, Bahar MR, et al. Relationship between the use of diuretics and overactive bladder in patients with heart failure. J Clin Anal Med. 2014;5:107–9. [Google Scholar]

12. Tannenbaum C, Johnell K. Managing therapeutic competition in patients with heart failure, lower urinary tract symptoms and incontinence. Drugs Aging. 2014;31:93–101. [PMC free article] [PubMed] [Google Scholar]

13. Hwang R, Chuan F, Peters R, Kuys S. Frequency of urinary incontinence in people with chronic heart failure. Heart Lung. 2013;42:26–31. [PubMed] [Google Scholar]

14. Lindeman K, Li Y, Palmer MH. Help-seeking for incontinence by individuals with heart failure. J Am Geriatr Soc. 2012;60:1994–5. [PMC free article] [PubMed] [Google Scholar]

15. Lee PG, Cigolle C, Blaum C. The co-occurrence of chronic diseases and geriatric syndromes: the health and retirement study. J Am Geriatr Soc. 2009;57:511–6. [PubMed] [Google Scholar]

16. Bierman AS. Coexisting illness and heart disease among elderly Medicare managed care enrollees. Health Care Financ Rev. 2004;25:105–17. [PMC free article] [PubMed] [Google Scholar]

17. Chiu AF, Liao CH, Wang CC, Wang JH, Tsai CH, Kuo HC. High classification of chronic heart failure increases risk of overactive bladder syndrome and lower urinary tract symptoms. Urology. 2012;79:260–5. [PubMed] [Google Scholar]

18. Rosa GM, Baccino D, Valbusa A, Scala C, Barra F, Brunelli C, et al. Cardiovascular effects of antimuscarinic agents and beta3-adrenergic receptor agonist for the treatment of overactive bladder. Expert Opini Drug Saf. 2018;17:487–97. [PubMed] [Google Scholar]

19. DuBeau CE, Kuchel GA, Johnson T, 2nd, Palmer MH, Wagg A, Fourth International Consultation on Incontinence Incontinence in the frail elderly: report from the 4th International Consultation on Incontinence. Neurourol Urodyn. 2010;29:165–78. [PubMed] [Google Scholar]

20. Kim HN, Januzzi JL., Jr Biomarkers in the management of heart failure. Curr Treat Options Cardiovasc Med. 2010;12:519–31. [PubMed] [Google Scholar]

21. Yoshimura K, Nakayama T, Sekine A, Matsuda F, Kosugi S, Yamada R, et al. B-type natriuretic peptide as an independent correlate of nocturnal voiding in Japanese women. Neurourol Urodyn. 2012;31:1266–71. [PubMed] [Google Scholar]

22. Raphael C, Briscoe C, Davies J, Ian Whinnett Z, Manisty C, Sutton R, et al. Limitations of the New York Heart Association functional classification system and self-reported walking distances in chronic heart failure. Heart. 2007;93:476–82. [PMC free article] [PubMed] [Google Scholar]

23. Lesman-Leegte I, Jaarsma T, Sanderman R, Linssen G, van Veldhuisen DJ. Depressive symptoms are prominent among elderly hospitalised heart failure patients. Eur J Heart Fail. 2006;8:634–40. [PubMed] [Google Scholar]

24. Grippo AJ. Mechanisms underlying altered mood and cardiovascular dysfunction: the value of neurobiological and behavioral research with animal models. Neurosci Biobehav Rev. 2009;33:171–80. [PMC free article] [PubMed] [Google Scholar]

25. Zorn BH, Montgomery H, Pieper K, Gray M, Steers WD. Urinary incontinence and depression. J Urol. 1999;162:82–4. [PubMed] [Google Scholar]

26. Choi JB, Kim YB, Kim BT, Kim YS. Analysis of heart rate variability in female patients with overactive bladder. Urology. 2005;65:1109–12. [PubMed] [Google Scholar]

27. Yu CJ, Hsu CC, Lee WC, Chiang PH, Chuang YC. Medical disease affecting lower urinary tract symptoms. Urol Sci. 2013;24:41–5. [Google Scholar]

28. Fitzgerald MP, Link CL, Litman HJ, Travison TG, McKinlay JB. Beyond the lower urinary tract: the association of urologic and sexual symptoms with common illnesses. Eur Urol. 2007;52:407–15. [PMC free article] [PubMed] [Google Scholar]

29. van Gerwen M, Schellevis F, Lagro-Janssen T. Comorbidities associated with urinary incontinence: a case-control study from the Second Dutch National Survey of General Practice. J Am Board Fam Med. 2007;20:608–10. [PubMed] [Google Scholar]

30. Coyne KS, Kaplan SA, Chapple CR, Sexton CC, Kopp ZS, Bush EN, et al. Risk factors and comorbid conditions associated with lower urinary tract symptoms: EpiLUTS. BJU Int. 2009;103 Suppl 3:24–32. [PubMed] [Google Scholar]

31. Faris R, Flather MD, Purcell H, Poole-Wilson PA, Coats AJ. Diuretics for heart failure. Cochrane Database Syst Rev. 2006;(1):CD003838. [PubMed] [Google Scholar]

32. Yip GW, Wang M, Wang T, Chan S, Fung JW, Yeung L, et al. The Hong Kong diastolic heart failure study: a randomised controlled trial of diuretics, irbesartan and ramipril on quality of life, exercise capacity, left ventricular global and regional function in heart failure with a normal ejection fraction. Heart. 2008;94:573–80. [PubMed] [Google Scholar]

33. Ekundayo OJ, Markland A, Lefante C, Sui X, Goode PS, Allman RM, et al. Association of diuretic use and overactive bladder syndrome in older adults: a propensity score analysis. Arch Gerontol Geriatr. 2009;49:64–8. [PMC free article] [PubMed] [Google Scholar]

34. Kazi D, Deswal A. Role and optimal dosing of angiotensin-converting enzyme inhibitors in heart failure. Cardiol Clin. 2008;26:1–14. [PubMed] [Google Scholar]

35. Hall SA, Chiu GR, Kaufman DW, Wittert GA, Link CL, McKinlay JB. Commonly used antihypertensives and lower urinary tract symptoms: results from the Boston Area Community Health (BACH) Survey. BJU Int. 2012;109:1676–84. [PMC free article] [PubMed] [Google Scholar]

36. Segall L, Nistor I, Covic A. Heart failure in patients with chronic kidney disease: a systematic integrative review. Biomed Res Int. 2014;2014:937398. [PMC free article] [PubMed] [Google Scholar]

37. Foody JM, Farrell MH, Krumholz HM. beta-Blocker therapy in heart failure: scientific review. JAMA. 2002;287:883–9. [PubMed] [Google Scholar]

38. Ruby CM, Hanlon JT, Fillenbaum GG, Pieper CF, Branch LG, Bump RC. Medication use and control of urination among community-dwelling older adults. J Aging Health. 2005;17:661–74. [PubMed] [Google Scholar]

39. Lewandowski J, Sinski M, Symonides B, Korecki J, Rogowski K, Judycki J, et al. Beneficial influence of carvedilol on urologic indices in patients with hypertension and benign prostatic hyperplasia: results of a randomized, crossover study. Urology. 2013;82:660–5. [PubMed] [Google Scholar]

40. Klatsky AL. Alcohol and cardiovascular diseases: where do we stand today? J Intern Med. 2015;278:238–50. [PubMed] [Google Scholar]

41. Partsch H. Compression therapy: clinical and experimental evidence. Ann Vasc Dis. 2012;5:416–22. [PMC free article] [PubMed] [Google Scholar]

42. van der Wal MH, van Veldhuisen DJ, Veeger NJ, Rutten FH, Jaarsma T. Compliance with non-pharmacological recommendations and outcome in heart failure patients. Eur Heart J. 2010;31:1486–93. [PubMed] [Google Scholar]

43. Andersson KE, Campeau L, Olshansky B. Cardiac effects of muscarinic receptor antagonists used for voiding dysfunction. Br J Clin Pharmacol. 2011;72:186–96. [PMC free article] [PubMed] [Google Scholar]

44. Rosa GM, Bauckneht M, Scala C, Tafi E, Leone Roberti Maggiore U, Ferrero S, et al. Cardiovascular effects of antimuscarinic agents in overactive bladder. Expert Opin Drug Saf. 2013;12:815–27. [PubMed] [Google Scholar]

45. Rosa GM, Ferrero S, Nitti VW, Wagg A, Saleem T, Chapple CR. Cardiovascular safety of β3-adrenoceptor agonists for the treatment of patients with overactive bladder syndrome. Eur Urol. 2016;69:311–23. [PubMed] [Google Scholar]

46. Thiagamoorthy G, Kotes S, Zacchè M, Cardozo L. The efficacy and tolerability of mirabegron, a β3 adrenoceptor agonist, in patients with symptoms of overactive bladder. Ther Adv Urol. 2016;8:38–46. [PMC free article] [PubMed] [Google Scholar]

SIX SYMPTOMS YOU SHOULD NOT IGNORE.

In most cases, soreness and pain are not symptoms of serious diseases, but some types of symptoms are subject to mandatory testing. If you observe any of the following phenomena, contact your doctor.

1. Chest pain

When it comes to chest pain, it’s better to be safe than sorry. Any chest pain, especially if accompanied by sweating, high blood pressure, shortness of breath, or nausea, should be evaluated immediately by a specialist. Chest pain or high blood pressure can be signs of heart disease or a heart attack, especially if these sensations occur during exercise or physical activity. In addition, chest pain may indicate other problems; for example, you have a blood clot that breaks off and travels to your lungs. If you have a feeling of tightness or heaviness in your chest that lasts more than a few minutes or goes away and comes back, seek help. Don’t try to endure it.

2. Weakness in the limbs

If you feel weakness and numbness in your arm, leg or face, it could be a sign of a stroke, especially if the symptom is on one side of your body. In addition, signs of a stroke include an inability to balance the body, dizziness, and difficulty walking. Seek help right away if your vision suddenly gets worse, you experience a severe headache, you feel disoriented, or you have trouble speaking and understanding speech. Detected at an early stage, this process is often reversible. Don’t delay seeking medical help. Call an ambulance. If you take a clot-dissolving drug within 4.5 hours of the first symptom of a stroke, you may reduce your risk of long-term disability after a stroke.

3. Sore and painful sensations in the back of the lower leg

These sensations may be a symptom of a blood clot in the leg. This phenomenon is called deep vein thrombosis (DVT). It can occur if you have been in a sitting position for a long time, such as on a long train ride or on a long flight, or if you have been ill and have been sitting in bed for a long time. If a blood clot has formed, you may feel pain when you stand or walk. You may also notice swelling. The leg is usually red and tender, and may increase in size compared to the other leg. It’s normal if you feel soreness after exercise. But if you see redness and feel a burning sensation where there is swelling or pain, call your doctor. You can also check for the presence of Gomans sign (pain in the calf muscles on palpation and with maximum dorsiflexion of the feet). If you try to bend your toes up and it hurts, that could also be indicative of a blood clot. But don’t rely on this sign alone. If the leg is hot, red, and swollen on one side, go to the intensive care unit. It is important to catch the blood clot before it breaks off and blocks your blood flow, which can lead to various complications.

4. Blood in the urine

Several things can cause blood in the urine. If you have blood in your urine and you also have pain in your side or back, you may have kidney stones. A kidney stone is a small crystal of minerals and salts that forms in your kidney and travels through the duct that drains urine. To diagnose the presence of stones, your doctor may order an x-ray or ultrasound. X-rays create images of your body’s organs using low-dose radiation. Ultrasound creates images using sound waves. In some cases, kidney stones can be passed out with urine. This is a very painful process. Sometimes your doctor may tell you that you need to have a kidney stone removed. If you have blood in your urine and have frequent urination or a burning sensation when urinating, you may have a severe bladder or kidney infection. Don’t hesitate to see a doctor, especially if you have a fever. If you see blood in your urine but don’t feel pain, it could be a sign of kidney or bladder cancer, so see your doctor.

5. Heavy breathing

Breathing problems should be treated immediately. If you wheeze or hear a whistling sound while breathing, see your doctor. Unless promptly assessed and treated promptly, breathing can quickly become difficult and even catastrophic. This condition can result from asthma, lung disease, severe allergies, or exposure to chemicals. Your doctor will find out what is causing it and what treatment is needed. If you have allergic asthma, your allergist or pulmonologist will create a treatment plan to help manage your asthma and reduce the number of flare-ups. In addition, wheezing can be caused by pneumonia or bronchitis. Are you coughing up yellow or green mucus? Do you have a fever or shortness of breath? If so, you may have bronchitis, which can progress to pneumonia.

6. Suicidal thoughts

If you feel hopeless or trapped, or if you have no reason to move on, you need help. Talking to a professional can help you get through the crisis. Go to the emergency room at a hospital or a clinic at a psychiatric hospital. A doctor or mental health professional will talk with you, help you stay safe and get through this difficult time.

Atrial fibrillation – symptoms and treatment

Other related articles: cardiologist

• aortic valve
  

• Arrhythmia
  

• Arrhythmias and COVID-19

• Arterial pressure
  

• Atherosclerosis
  

• Atherosclerosis of the extremities
  

• Atherosclerosis of the brain
  

• vascular atherosclerosis
  

• Bradycardia in children
  

• Pediatric cardiology
  

• Ischemic disease
  

• Cardiologist
  

• Atrial fibrillation
  

• Rhythm disturbances
  

• Obliterating atherosclerosis
  

• sinus arrhythmia
  

• Sinus tachycardia
  

• Vessels of the limbs
  

• angina pectoris
  

• Tachycardia
  

• What is Bradycardia
  

Atrial fibrillation is a serious and dangerous disease and requires specialized treatment.

Atrial fibrillation – is a heart rhythm disturbance, which is accompanied by frequent, chaotic excitation and contraction of the atria, fibrillation of individual groups of atrial muscle fibers. Heart rate in this disease reaches 350-700 per minute. Atrial fibrillation is a serious and dangerous disease and requires specialized treatment.

Forms of pathology:

• Transient – attacks occur with a small frequency, last no more than two days, usually disappear on their own.
• Persistent – seizures last more than 7 days, disappear only after taking medications.
• Chronic – continues until surgery and is determined by the failure of electrical cardioversion.

Causes of atrial fibrillation:

• Excessive drinking and smoking
• Taking narcotic or psychotropic substances
• Long-term use of weight loss products
• Diseases of the thyroid gland
• Diseases of the kidneys
• Chronic stress
• Deficiency in the body of magnesium and potassium
• Endocrine disorders
• High blood pressure
• Malnutrition
• Diabetes mellitus
• Staying under water for a long time without air
• Heart defects
• Strokes
• Age
• Serious viral, bacterial infections
• Electric shock

Symptoms of atrial fibrillation:

• Pain in the region of the heart and chest
• Dizziness and syncope
• Excessive sweating
• Shortness of breath
• Feeling of labored breathing and shortness of breath
• Palpitations
• Frequent urination
• Strong fear, panic
• Weakness

Treatment of atrial fibrillation

Drug treatment – intravenous and internal medication.

Cardioversion – an electric shock of a certain power “restarts” the heart and causes it to contract correctly.

RF catheter ablation – cauterization of the pathological area in the myocardium, which is the cause of the arrhythmia. During the treatment, the doctor leads the conductor through the femoral artery directly to the heart, gives an electrical impulse that eliminates all disorders.

Ablation with the installation of a pacemaker – the atrioventricular node is destroyed, causing a complete blockade, and then an artificial pacemaker is implanted.

Cardioverter-defibrillator insertion – the device is sewn into the upper chest subcutaneously and is used to immediately stop an arrhythmia attack.

Labyrinth operation – incisions are made in the atria in the form of a labyrinth, which will redirect electrical impulses, and the organ will continue to work normally.